ArticleThe Journal of dermatology2022

Real-world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all-case postmarketing surveillance in Japan.

Naoya Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.